These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 14145228)

  • 1. SINGLE DAILY DOSE REGIMEN OF ISONIAZID AND PAS IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    WILSON JL; LAMPE WT
    Am Rev Respir Dis; 1964 May; 89():756-9. PubMed ID: 14145228
    [No Abstract]   [Full Text] [Related]  

  • 2. A CONTROLLED COMPARISON OF STREPTOMYCIN PLUS PYRAZINAMIDE AND STREPTOMYCIN PLUS PAS IN THE RETREATMENT OF PATIENTS EXCRETING ISONIAZID-RESISTANT ORGANISMS.
    VELU S; DAWSON JJ; DEVADATTA S; FOX W; KULKARNI KG; MOHAN K; RAMAKRISHNAN CV; STOTT H
    Tubercle; 1964 Jun; 45():144-59. PubMed ID: 14161913
    [No Abstract]   [Full Text] [Related]  

  • 3. ["PERSISTANCE" OF THE "SENSITIVE" KOCH BACILLI. CLINICO-EXPERIMENTAL STUDY].
    LERNER S
    Rev Esp Tuberc; 1963 Oct; 32():497-505. PubMed ID: 14123028
    [No Abstract]   [Full Text] [Related]  

  • 4. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZAJACZKOWSKA J; JANCZY S; BURACZEWSKA M; KORLAKOWSKI J; ZYCH D; KRYCHNIAK W
    Gruzlica (1926); 1964 Feb; 32():89-95. PubMed ID: 14136692
    [No Abstract]   [Full Text] [Related]  

  • 5. [ANTIMICROBIAL TREATMENT OF TUBERCULOSIS WITH SUBSIDIARY DRUGS. 2ND LINE DRUGS].
    ACEVEDO RC; HERRERO JJ; PILHEU J; RODRIGUEZ E
    Sem Med; 1964 Mar; 124():534-43. PubMed ID: 14156391
    [No Abstract]   [Full Text] [Related]  

  • 6. PULMONARY TUBERCULOSIS IN RETROSPECT AND PROSPECT.
    THOMAS CP
    Ann R Coll Surg Engl; 1964 Aug; 35(2):67-83. PubMed ID: 14180407
    [No Abstract]   [Full Text] [Related]  

  • 7. MONOTHERAPY WITH 4-4'DIISOAMYLOXYTHIO-CARBANILIDE (ISOXYL).
    Acta Tuberc Pneumol Scand; 1964; 44():327-34. PubMed ID: 14166154
    [No Abstract]   [Full Text] [Related]  

  • 8. [TRIPLE SCHEMA IN THE TREATMENT OF TUBERCULOSIS].
    LAUROC DE
    Rev Paul Med; 1964 Jan; 64():57-62. PubMed ID: 14137921
    [No Abstract]   [Full Text] [Related]  

  • 9. [AMBULATORY TREATMENT OF NON-TREATED TUBERCULOSIS PATIENTS. PRELIMINARY REPORT].
    SENTIES R; CERVERA N; CASTILLONAVA J
    Neumol Cir Torax; 1964; 25():21-5. PubMed ID: 14115176
    [No Abstract]   [Full Text] [Related]  

  • 10. THE TOLERANCE OF ISONIAZID IN ONE DAILY DOSE.
    BRANDER L
    Acta Tuberc Pneumol Scand; 1964; 43():299-306. PubMed ID: 14166440
    [No Abstract]   [Full Text] [Related]  

  • 11. THE RESULTS OF DIFFERENT METHODS OF CHEMOTHERAPY IN THE TREATMENT OF PULMONARY TUBERCULOSIS.
    SUN TN; TENG WW; YUE CJ
    Chin Med J; 1964 Mar; 83():155-62. PubMed ID: 14214235
    [No Abstract]   [Full Text] [Related]  

  • 12. CHEMOTHERAPY OF TUBERCULOSIS: A BACTERIOLOGIST'S VIEWPOINT.
    MITCHISON DA
    Br Med J; 1965 May; 1(5446):1333-40. PubMed ID: 14278838
    [No Abstract]   [Full Text] [Related]  

  • 13. [1-YEAR RESULTS OF ANTIBACTERIAL THERAPY OF RECENTLY DISCOVERED CAVERNOUS PULMONARY TUBERCULOSIS].
    ZIERSKI M; BEK E; SIWINSKA I; WOZNIAK S
    Gruzlica (1926); 1964 Feb; 32():97-105. PubMed ID: 14136693
    [No Abstract]   [Full Text] [Related]  

  • 14. [COMBINATION OF ETHIONAMIDE AND P-AMINOSALICYLIC ACID IN THE TREATMENT OF PULMONARY TUBERCULOSIS WITH GERMS RESISTANT TO ISONIAZID AND STREPTOMYCIN].
    PEREZ JA; FARIAS CE; AMADIO G; CAFURE N
    Prensa Med Argent; 1963 Dec; 50():3280-1. PubMed ID: 14184234
    [No Abstract]   [Full Text] [Related]  

  • 15. BLOOD CONCENTRATIONS OF PAS PRODUCED BY A MIXTURE OF PAS AND THE PHENYL ESTER OF PAS.
    MORRIS D
    Tubercle; 1963 Dec; 44():480-3. PubMed ID: 14101329
    [No Abstract]   [Full Text] [Related]  

  • 16. SOME PROBLEMS IN THE MANAGEMENT OF TUBERCULOSIS.
    MITCHELL JH
    Br J Clin Pract; 1964 Feb; 18():63-8. PubMed ID: 14115576
    [No Abstract]   [Full Text] [Related]  

  • 17. [CLINICAL TRIAL OF 3 TYPES OF ORAL TREATMENT OF PULMONARY TUBERCULOSIS. (ISONIAZID+ETHIONAMIDE, ISONIAZID + PAS, ISONIAZID ALONE)].
    LEHIR M; CHICOU J; HETRICK G; MERCIER A; NEEL R; RIST N
    Bull World Health Organ; 1964; 30(5):701-32. PubMed ID: 14196816
    [No Abstract]   [Full Text] [Related]  

  • 18. CHEMOTHERAPY FOR PATIENTS WITH CULTURES RESISTANT TO STREPTOMYCIN, ISONIAZID AND PAS.
    JANCIK E; ZELENKA M; TOUSEK J; MAKOVA M
    Tubercle; 1963 Dec; 44():443-5. PubMed ID: 14101324
    [No Abstract]   [Full Text] [Related]  

  • 19. A CONTROLLED CLINICAL TRIAL OF ISONIAZID AND HETEROCYCLIC THIOSEMICARBAZONE COMPARED WITH ISONIAZID AND PAS IN PULMONARY TUBERCULOSIS.
    JANCIK E; TOUSEK J; MAKOVA M; ZELENKA M
    Tubercle; 1963 Dec; 44():431-42. PubMed ID: 14101323
    [No Abstract]   [Full Text] [Related]  

  • 20. A STUDY OF THE INFLUENCE OF THE ISONIAZID INACTIVATOR PHENOTYPE ON REVERSION IN GENITO-URINARY TUBERCULOSIS.
    GOW JG; EVANS DA
    Tubercle; 1964 Jun; 45():136-43. PubMed ID: 14161912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.